Merit Medical Systems, Inc. (MMSI)
Market Cap | 4.30B |
Revenue (ttm) | 1.26B |
Net Income (ttm) | 94.41M |
Shares Out | 57.93M |
EPS (ttm) | 1.62 |
PE Ratio | 45.88 |
Forward PE | 21.98 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 103,811 |
Open | 73.69 |
Previous Close | 74.18 |
Day's Range | 73.37 - 74.64 |
52-Week Range | 62.58 - 85.62 |
Beta | 0.91 |
Analysts | Buy |
Price Target | 89.50 (+20.54%) |
Earnings Date | Apr 30, 2024 |
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bo... [Read more]
Financial Performance
In 2023, MMSI's revenue was $1.26 billion, an increase of 9.24% compared to the previous year's $1.15 billion. Earnings were $94.41 million, an increase of 26.70%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is $89.5, which is an increase of 20.54% from the latest price.
News
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve succe...
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...
Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320 Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
SOUTH JORDAN, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today introduced its Continued Gr...
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...
Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System
New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries New guidance system marks signifi...
First Patient Enrolled in Merit Medical's MOTION Study
SOUTH JORDAN, Utah, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the successful en...
Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024
* Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP ...
Merit Medical Announces Process for Chief Executive Officer Succession Planning
SOUTH JORDAN, Utah, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today outlined the ongoing succes...
Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
SOUTH JORDAN, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced the pricing o...
Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
SOUTH JORDAN, Utah, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq: MMSI) (“Merit”), a leading global manufacturer and marketer of healthcare technology, announced today that it...
Merit Medical Reports Results for Third Quarter Ended September 30, 2023
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...
Merit Medical Launches Expanded Maestro® Microcatheter Line
New multipurpose microcatheter length complements Merit's radial-first legacy New multipurpose microcatheter length complements Merit's radial-first legacy
Merit Medical Systems to Announce Third Quarter 2023 Results on October 26, 2023
SOUTH JORDAN, Utah, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients Advanced design complements comprehensive drainage portfolio, expanding...
Merit Medical's WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of...
Merit Medical Reports Results For Second Quarter June 30, 2023
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-...
Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023
SOUTH JORDAN, Utah, July 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rele...
Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.
SOUTH JORDAN, Utah, June 08, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced it has completed ...
Merit Medical Announces New Five-Year Senior Secured Credit Agreement
Credit agreement includes a revolving credit facility of up to $700 million and a term loan facility of up to $150 million Credit agreement includes a revolving credit facility of up to $700 million a...
Merit Medical Reports Results for First Quarter March 31, 2023
Q1 2023 reported revenue of $297.6 million, up 8.0% compared to Q1 2022 Q1 2023 constant currency revenue, organic* up 9.8% compared to Q1 2022 Q1 2023 GAAP operating margin of 8.9%, compared to 5.5% ...
Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
SOUTH JORDAN, Utah, April 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will rel...
Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering
New sizes of advanced articulating microcatheter enhance a market-leading portfolio of vascular access products New sizes of advanced articulating microcatheter enhance a market-leading portfolio of v...
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance
* Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-G...
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
Next-generation system helps improve surgical precision to enhance patient care in breast and other soft tissue cancer treatment Next-generation system helps improve surgical precision to enhance pati...